KP
Equillium Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Itolizumab (EQ001) | Acute Graft-Versus-Host Disease (aGVHD) | Phase 1b |
| EQ504 | Inflammatory disorders (via AhR modulation) | Preclinical/Discovery |
| Multi-Cytokine Inhibitor Platform | Numerous inflammatory conditions | Discovery/Preclinical |